For 2025, West Pharmaceutical guided for sales between $2.88 billion and $2.91 billion as well as adjusted earnings per-share in the range of $6 and $6.20. Analysts polled by FactSet expected $3.04 billion in sales and $7.45 a share in adjusted earnings.

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels,

West Pharmaceutical Services Inc . (NYSE:WST) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $1.82 compared to the forecasted $1.72. Despite this positive earnings surprise,